Partner Therapeutics, Inc. (PTx), a private, fully integrated biotechnology company, announced that results from the ...

Sarepta Therapeutics, Inc. , the leader in precision genetic medicine for rare diseases, today announced that the U.S. Food ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

When developing therapies, maintaining protein stability and preventing aggregation is essential. It is now time to move beyond traditional flow cell imaging techniques. Using Aura PTx, formulation ...

Ligand Pharmaceuticals has delivered exceptional long-term returns, rising from ~$86 to nearly $300 over six years. Read why LGND stock is a Buy.

Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...

The hyperspace of reaction conditions of the Biginelli reaction is scanned using a robotic platform, revealing a pseudo-seven-component transformation that yields a bicyclic product featuring rare ...

General adaptation syndrome (GAS) describes the three-stage process your body goes through when under stress: alarm, resistance, and exhaustion. Short-term stress during the alarm stage isn’t harmful ...

Arizona Gold and Silver Inc. continues the hunt for large, high-grade targets at its projects in the US state ...

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and ...